Biotech success, 2002 | Stock Discussion Forums

Sponsor

Biotech / Medical: Biotech success, 2002

Posts: 117 | Member SubjectMarks: 20 | No Bans

Add SubjectMark | Hide Original Post | Show Chart | Poster Summary | Share This Board

Moderated By: Miljenko Zuanic -- (Not Moderated) -- Started: 1/16/2002 7:08:09 PM Revision History

To counter-balance tread *biotech-failure, 2002*

Subject 52275

This tread is to record significant achievement and success from bios.

Please no crap-shot.

News that may qualify should report:
1. Scientific achievement which will *shake* sector
2. Significant positive PIIb or PIII results
3. NDA (ANDA) submission and approval
4. Large collaboration-partnership
5. Unexpected strong market penetration
6. ...

Miljenko

Previous 10 | Next 10 | View Recent | Post Message

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Date
117	Velcade approval - [graphic]Message 18941041	nigel bates	-	05/13/2003 07:06 PM
116	BioMarin, Genzyme Announce FDA Marketing Approval for Aldurazyme NOVATO, Calif.	nigel bates	-	05/01/2003 03:08 AM
115	re: AMEX: IMA @ $16 (Inverness Medical Innnovation) not a typical biotech compa	Crossy	-	01/28/2003 07:13 AM
114	seems the fda is realy changing its pace Welcome, dalroi [Sign Out] Money Man	dalroi	-	01/01/2003 01:32 PM
113	Have no idea was Eyetech deal mentioned anywhere at SI, but bios (we) have two n	Miljenko Zuanic	-	12/20/2002 01:54 AM
112	I think the Diversa / Syngenta research deal is just about big enough to make th	nigel bates	-	12/04/2002 05:38 AM
111	Certainly a success for Antisoma - Roche to acquire rights to promising portfol	nigel bates	-	11/18/2002 04:41 AM
110	Lots of talk, but very little data presented! Press Release Source: The Medicin	Miljenko Zuanic	-	11/17/2002 03:42 PM
109	Angiomax success. (sorry, couldn't get format right.) biz.yahoo.com	WilderElisimo	-	11/17/2002 02:10 PM
108	Press Release Source: Eli Lilly REPEAT/Cialis -- tadalafil -- Approved by Eur	Miljenko Zuanic	-	11/14/2002 10:35 PM
107	NBIX Trial biz.yahoo.com	Elmer	-	11/14/2002 08:00 AM

Go to reply# or date (mm/dd/yy):